title: Transfemoral TAVI devices: design overview and clinical outcomes.
abstract: Over the last decade, transcatheter aortic valve implantation (TAVI) has gained widespread acceptance for the treatment of high surgical risk or inoperable patients with severe aortic stenosis. Spurred on by initial success and an ever-growing body of supporting data, TAVI has undergone rapid technological advancements in recent years with a focus on procedural simplification and limiting complications associated with the early devices. In this article, we provide a brief overview of the past, current and newer devices for transfemoral (TF) TAVI and their post-procedural outcomes.
authors.affiliation: Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany.
authors.forename: Mohamed
authors.initials: M
authors.lastname: Abdel-Wahab
authors.forename: John
authors.initials: J
authors.lastname: Jose
authors.forename: Gert
authors.initials: G
authors.lastname: Richardt
mesh_terms: D001021:Aortic Valve / Q000503:physiopathology; D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D063126:Balloon Valvuloplasty; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D002406:Catheterization, Peripheral / Q000379:methods; D005263:Femoral Artery; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D006801:Humans; D018579:Patient Selection; D011474:Prosthesis Design; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome